Cryptococcosis is a life-threatening disease caused by the ubiquitous, eukaryotic organism, Cryptococcus neoformans. With the greater use of immunosuppressive drugs and the AIDS epidemic, there is a growing number of individuals suffering from cryptococcosis. Both human and animal studies, clearly document that the cell-mediated immune (CMI) response is the major protective host defense against this encapsulated yeast-like organism. The CMI response is a complex cascade of biological events involving numerous leukocytes, cytokines, and chemokines (chemoattractant cytokines), and when appropriately orchestrated, the CMI components eliminate cryptococci from tissues. Although it is evident that T lymphocytes functioning in the CMI response are important in protection against cryptococci, the mechanisms by which the T cells exert their activity have not been completely elucidated. Both CD4 and CD8 subsets of T cells contribute to protection; however, CD4 cells have a greater impact. The major long-term goal of this project is to gain an understanding of the sequence of biological events and factors that influence clearance of cryptococci, so that measures can be devised to reestablish a protective pathway in immunodeficient individuals through immunoreplacement or immunomodulatory therapeutic procedures. We propose to focus attention on understanding the details of the expression phase of the anticryptococcal CMI response, because it is through this phase of the response that the organism is eliminated. Recently we have developed a means of eliciting a CMI reaction to cryptococcal antigen (CneF) in a gelatin sponge matrix implanted into the backs of immune mice. This procedure allows us to retrieve and examine the fluid and cells from the reaction site. Thus far, we have defined the kinetics of cellular infiltrates into the CMI-reactive sponges and established that TNF, IL-2, IFNgamma, and IL-5 are produced as a part of the reaction. In this application, we propose to use the gelatin sponge model to further define the cells, cytokines, and chemokines and their function in clearance of C. neoformans from immune and naive mice. Experiments will be done to test ways of modulating the response to achieve greater protective capacity. Finally, we will determine if the factors (cells, cytokines, and chemokines) associated with limited growth of cryptococci in the sponges are also functional in infected tissues such as lung, spleen, liver, and - brain. Findings from the proposed studies with CneF immunization and cryptococcal infection models, along with appropriate controls, should provide the necessary knowledge to devise effective vaccines or immunotherapy against C. neoformans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI015716-18
Application #
2003191
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1980-04-01
Project End
1998-12-31
Budget Start
1997-01-01
Budget End
1997-12-31
Support Year
18
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Jackson, Lydgia A; Drevets, Douglas A; Dong, Zhao-Ming et al. (2005) Levels of L-selectin (CD62L) on human leukocytes in disseminated cryptococcosis with and without associated HIV-1 infection. J Infect Dis 191:1361-7
Blackstock, Rebecca; Murphy, Juneann W (2004) Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells. Infect Immun 72:5175-80
Bauman, Sean K; Huffnagle, Gary B; Murphy, Juneann W (2003) Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun 71:68-74
Nichols, Kasie L; Bauman, Sean K; Schafer, Fredda B et al. (2002) Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans. Infect Immun 70:591-600
Bauman, S K; Nichols, K L; Murphy, J W (2000) Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol 165:158-67
McGaha, T; Murphy, J W (2000) CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response. Infect Immun 68:4624-30
Blackstock, R; Buchanan, K L; Cherniak, R et al. (1999) Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia 147:1-11
Doyle, H A; Murphy, J W (1999) Role of the C-C chemokine, TCA3, in the protective anticryptococcal cell-mediated immune response. J Immunol 162:4824-33
Blackstock, R; Buchanan, K L; Adesina, A M et al. (1999) Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun 67:3601-9
Huffnagle, G B; McNeil, L K; McDonald, R A et al. (1999) Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol 163:4642-6

Showing the most recent 10 out of 37 publications